This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


  • Give Up Peanut Butter? I’ll Take My Chances on Salmonella Instead
    No, that’s not me talking, but rather the headline that could have run on a piece from The Washington Post on why U.S. consumers are loathe to give up their favorite foods, even in the midst of a product recall such as the one regarding peanut paste products. Flying ...More
    February 4, 2009 Posted in Blogs
  • Nanoemulsion Potent Against Superbugs Killing Cystic Fibrosis Patients
    University of Michigan scientists report highly encouraging evidence that a super-fine oil-and-water emulsion, already shown to kill many other microbes, may be able to quell the ravaging, often drug-resistant infections that cause nearly all cystic fibrosis deaths.Cystic ...More
    February 4, 2009 Posted in News, PPE & Standard Precautions
  • South Carolina Hospitals to Eliminate Infections, Reduce Cost of Care
    In an effort to reduce avoidable deaths, patient harm and healthcare costs, all 65 acute-care hospitals in South Carolina have joined a collaborative aimed at eliminating preventable healthcare-associated infections (HAIs) statewide while safely reducing associated costs. ...More
    February 4, 2009 Posted in News
  • Scientists Discover How Deadly Fungus Protects Itself
    Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a deadly microbe evades the human immune system and causes disease. The study, published in the journal Proceedings of the National Academy of Sciences (PNAS), may help scientists ...More
    February 3, 2009 Posted in News
  • Mandatory MRSA Screening
    Did you know that by the end of March it will become mandatory for acute-care hospitals in England to screen all elective patient admissions for MRSA? For more details, check out this news item from by clicking HERE.  ...More
    February 3, 2009 Posted in Blogs
  • Potential New Herpes Therapy Studied
    A new therapy being developed at the University of Florida could, in time, produce another weapon for the fight against herpes.The gene-targeting approach uses a specially designed RNA enzyme to inhibit strains of the herpes simplex virus. The enzyme disables a gene ...More
    February 3, 2009 Posted in News
  • Researchers Find Enzyme Unique to Tularemia Organism
    Researchers are closer to developing therapies to combat the deadly tularemia infection, according to a study published this week in the Proceedings of the National Academy of Sciences' online Early Edition. Karl Klose, director of the South Texas Center for Emerging ...More
    February 3, 2009 Posted in News
  • Comparative Genomics Reveals Molecular Evolution of Q Fever Pathogen
    Scientists from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center, and the Virginia Bioinformatics Institute at Virginia Tech have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than ...More
    February 2, 2009 Posted in News
  • New Vaccine Developed for Preventing “Uncommon” Cold Virus
    Common colds typically cause a week of sneezing, aches and pains and then fade away leaving only a sore nose and a few used sick days behind. But what if that cold turned out to be something more? Human adenovirus type-3 is known as the “uncommon cold” because ...More
    February 2, 2009 Posted in News
  • Nominations for 2009 ICT Who’s Who Issue
    The Who's Who in Infection Prevention section in the June 2009 issue of Infection Control Today magazine will recognize outstanding individuals making significant contributions to infection prevention and control in an acute-care environment. Our call for nominations is now ...More
    February 2, 2009 Posted in Blogs